Calcium requirement for cGMP production during muscarinic activation of N1E-115 neuroblastoma cells

S H Thompson1, C Mathes, A A Alousi

  • 1Department of Biological Sciences, Stanford University, Pacific Grove, California 93950, USA.

Insights

Muscarinic agonists increase intracellular calcium and cyclic GMP (cGMP) in neuroblastoma cells. Calcium influx and release must summate to activate nitric oxide synthase (NOS) for cGMP production.

Area of Science:

  • Neuroscience
  • Cell Signaling
  • Biochemistry

Background:

  • Muscarinic agonists stimulate intracellular Ca2+ and cGMP in N1E-115 neuroblastoma cells.
  • Elevated intracellular Ca2+ ([Ca2+]i) is essential for cGMP accumulation.

Purpose of the Study:

  • To investigate the role of intracellular Ca2+ dynamics in nitric oxide synthase (NOS) activation and cGMP production.
  • To determine the contribution of Ca2+ influx versus Ca2+ release to cGMP synthesis.

Main Methods:

  • Utilized Ca2+ buffering with BAPTA to assess the necessity of [Ca2+]i increase.
  • Inhibited NOS to evaluate its role in cGMP production.
  • Manipulated extracellular Ca2+ concentrations and used thapsigargin to study Ca2+ influx and release.

Main Results:

  • Ca2+-dependent NOS activation is required for cGMP production.
  • Ca2+ influx is strongly coupled to cGMP production, though Ca2+ release contributes more to the peak [Ca2+]i.
  • Summation of Ca2+ influx and release is necessary to reach the threshold for cGMP accumulation.

Conclusions:

  • Ca2+ influx and release synergize to activate NOS and stimulate cGMP production.
  • NOS or its activators may be localized near membrane Ca2+ channels due to the significant role of Ca2+ influx.